Finland
Tuberculosis profile
Population  2013 5.4 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.017 (0.017–0.018) 0.32 (0.32–0.32)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.37 (0.13–0.72) 6.8 (2.5–13)
Incidence  (includes HIV+TB) 0.31 (0.29–0.34) 5.7 (5.3–6.2)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.02–0.05)
Case detection, all forms (%) 85 (79–92)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.62 (0.02–3.4) 0 (0–52)
MDR-TB cases among notified pulmonary
TB cases
1 (0–7) 0 (0–6)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 173   6
Pulmonary, clinically diagnosed 34   0
Extrapulmonary 51   2
       
Total new and relapse 266    
Previously treated, excluding relapses 5    
Total cases notified 271    
Among 266 new and relapse cases:
2 (<1%) cases aged under 15 years; male:female ratio: 1.6
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 206 (119%) 5 (38%) 206
Laboratory-confirmed RR-/MDR-TB cases     2
Patients started on MDR-TB treatment     2
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 44
Previously treated cases, excluding relapse, registered in 2012 55
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-05-30 Data: www.who.int/tb/data